Hospital At Home Waiver Extended To 2030

Burlington, Vermont. A federal waiver extending the hospital-at-home program through September 2030 has secured funding for a care model that brings hospital-level treatment to patients' residences. The extension, passed with bipartisan support, resolves uncertainty that had lingered since the program began as a temporary measure during the pandemic. More than 30,000 patients have used the service nationwide to date.

The program allows stable patients to receive care at home under strict monitoring protocols. Colleen Callahan, 75, of Peoria, Illinois, was diagnosed with bacterial pneumonia in both lungs in 2024. After three days in a traditional hospital setting, staff from OSF Healthcare offered her a transfer to their OnCall Digital Hospital unit. Callahan initially hesitated, worrying she was not well enough to leave the medical center. She later accepted the offer and spent five days receiving care in her own bed.

The service requires patients to live within 30 minutes of the operating hospital and be stable enough for remote monitoring. OSF provides all necessary equipment, including a tablet for video visits, remote monitoring devices, and internet service. Nurses visit at least twice daily, while doctors conduct virtual check-ins. Melissa Meier, manager of digital care at OSF OnCall, stated that clear protocols allow staff to act quickly if a patient's condition changes, including returning them to the medical center if needed.

The program treats conditions ranging from infections to chronic illnesses like congestive heart failure and COPD. Akin Demehin of the American Hospital Association described the model as one of the most promising care innovations in recent years. Similar programs are currently active at more than 350 hospitals across the country. Demehin noted that patients are generally billed at the same rates as in-hospital stays, with insurance coverage remaining consistent. A 2024 study by the Centers for Medicare and Medicaid Services found that readmission rates for certain conditions and hospital-acquired infections are lower for patients treated at home compared to those treated in traditional facilities.

Tom Kiesau of the healthcare consulting firm Chartis Group highlighted the economic implications of the model. He noted that lower spending in the post-discharge period and reduced hospitalizations could translate into savings for the government and taxpayers. Kiesau emphasized the urgent need for the model, stating that the aging population is creating a capacity crisis that current hospital infrastructure cannot fully address. Krista Drobac of Moving Health Home expressed relief at the regulatory certainty provided by the new waiver. She advocates for the program to become a permanent fixture in the healthcare system, arguing it aligns with patient preferences for care in familiar settings.

Caregiver advocates have raised concerns about the potential strain on family members. A 2022 study in JAMA Health Forum suggested the program did not sufficiently consider the role of family caregivers. However, Drobac pointed to research indicating that caregivers often feel less stress because they have professional support to consult. Callahan reported that her husband and daughter felt supported during her treatment. She described the experience as more personal than a hospital stay, comparing it to an old-fashioned doctor making house calls. According to Moving Health Home, 85% of patients who received care through the program said they would recommend it to family and friends.

The program is voluntary and does not replace all hospital services. Demehin clarified that surgeries and other procedures that require specialized equipment will still take place within medical centers. The waiver allows hospitals to continue treating patients at home and receiving federal payment for those services. The next phase of the program's development depends on Congress deciding whether to make the funding permanent beyond the 2030 deadline.